Referencias: Guía detallada de los tumores de encéfalo y los tumores de médula espinal

Altekruse SF, Kosary CL, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Accessed on March 2, 2011.

American Cancer Society. Cancer Facts & Figures 2012. Atlanta, Ga; 2012.

Central Brain Tumor Registry of the United States (CBTRUS). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20004-2007. Central Brain Tumor Registry of the United States; 2011. Accessed at www.cbtrus.org/2011-NPCR-SEER/WEB-0407-Report-3-3-2011.pdf on March 4, 2011.

Maity A, Pruitt AA, Judy KD, et al. Cancer of the central nervous system. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:1075–1136.

Mehta MP, Buckner JC, Sawaya R, Cannon G. Neoplasms of the central nervous system. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008:1975–2032.

National Cancer Institute Physician Data Query (PDQ). Adult Brain Tumors Treatment. 2010. Accessed at www.cancer.gov/cancertopics/pdq/treatment/adultbrain/healthprofessional on March 9, 2011.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers. V.2.2011. Accessed at www.nccn.org/professionals/physician_gls/PDF/cns.pdf on March 9, 2011.

Prados MD. Primary neoplasms of the central nervous system in adults. In: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E, eds. Cancer Medicine 7. Hamilton, Ontario: BC Decker; 2006:1037–1064.

Sampson JH, Heimberger AB, Archer GE, et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J Clin Oncol. 2010;28:4722−4729.